On 26 April,MSD Pharmaceuticals ,the Indian arm of Merck&Co., the world's #5 drug maker launched its patented anti-diabetes (type 2) drug,Januvia,in India.Already a best-seller in the US ,the drug uses a new class of molecules that enhances the body's own ability to lower blood sugar when it is elevated.
Naveen A . Rao ,the MD of MSD , said that the next on his radar are drugs for other major ailments in the country like dylipidemia( high cholesterol) and cervical cancer ,which is more prevalent than breast cancer among Indian women
source:-Business Today,May 18, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment